2021 / 06

Next Paper
DOI: 10.24075/brsmu.2021.067

CLINICAL CASE

Long-term effects of multimodality laser therapy in patient with drusenoid pigment epithelial detachment

Takhchidi KhP, Takhchidi NKh, Kasmynina TA, Mahno NA
About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Nadezhda A. Mahno
Volokolamskoe shosse, 30, korp. 2, Moscow, 123182, Russia; moc.liamg@7onham.adzedan

About paper

Author contribution: Takhchidi KhP — study concept and design, manuscript editing; Takhchidi NKh — literature analysis; Kasmynina TA — laser therapy; Mahno NA — data acquisition and processing, manuscript writing.

Compliance with ethical standards: the patients submitted the informed consent to laser therapy and personal data processing.

Received: 2021-11-24 Accepted: 2021-12-16 Published online: 2021-12-29
|
  1. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2 (2): 106–16.
  2. Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR; Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120 (4): 844–51.
  3. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. British Journal of Ophthalmology. 1985; 69: 397–403.
  4. Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK; Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology. 2020; 127 (5): 616–36.
  5. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye (Lond). 1994; 8: 269–83.
  6. Balaratnasingam C, Yannuzzi LA, Curcio CA, Morgan WH, Querques G, Capuano V, et al. Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments. Invest Ophthalmol Vis Sci. 2016; 57 (13): 5479–89.
  7. Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, et al. Age-Related Eye Disease Study 2 Research Group. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology. 2019; 126 (2): 261–73.
  8. Roquet W, Roudot-Thoraval F, Coscas G, Soubrane G. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol. 2004; 88 (5): 638–42.
  9. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, et al. Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013; 120 (8): 1604–11.
  10. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology. 2006; 113 (11): 1974–86.
  11. Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR. Laser treatment of drusen to prevent progression to advanced agerelated macular degeneration. Cochrane Database Syst Rev. 2015; 10 (10): 1–67.
  12. Prahs P, Walter A, Regler R, Theisen-Kunde D, Birngruber R, Brinkmann R, Framme C. Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2010; 248 (5): 651–8.
  13. Guymer RH, Wu Z, HodgsonL AB, Caruso E, Brassington KH, Tindill N, et al. Laser Interventionin Early Stages of Age-Related Macular Degeneration Study Group. Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019; 126 (6): 829–38.
  14. Gordeeva MV, Gacu MV. Funkcional'nye rezul'taty porogovoj lazerkoaguljacii razlichnyh vidov mjagkih makuljarnyh druz. Vestnik OGU. 2013; 4 (153); 59–62. Russian.
  15. Gordeeva MV. Sravnenie jeffektivnosti razlichnyh lazernyh metodik lechenija mjagkih makuljarnyh druz [dissertacija]. M., 2013. Russian.
  16. Novais EA, Badaró E, Regatieri CV, Duker J, de Oliveira Bonomo PP. Regression of drusen after combined treatment using photodynamic therapy with verteporfin and ranibizumab. Ophthalmic Surg Lasers Imaging Retina. 2015; 46 (2): 275–8.
  17. Gallego-Pinazo R, Marina A, Suelves-Cogollos, Francés-Muñoz E, Millán JM, Arevalo JF, et al. Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration. Clin Ophthalmol. 2011; 5: 161–5.
  18. Vavvas DG, Daniels AB, Kapsala ZG, Goldfarb JW, Ganotakis E, Loewenstein JI, et al. Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment. EBioMedicine. 2016; 5: 198–203.